Aft, Forsyth & Company, Inc. Eli Lilly & CO Transaction History

Aft, Forsyth & Company, Inc.

$174 Million
Q1 2024

A detailed history of Aft, Forsyth & Company, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 6,440 shares of LLY stock, worth $6.11 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

6,440

Previous 7,030 8.39%

Holding current value

$6.11 Million

Previous $4.1 Million 22.28%

% of portfolio

2.88%

Previous 2.59%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $349,398 - $467,445	-590 Reduced 8.39%	6,440 $5.01 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $86,656 - $102,156	165 Added 2.4%	7,030 $4.1 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $82,593 - $113,866	190 Added 2.85%	6,865 $3.69 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $59,625 - $79,726	-170 Reduced 2.48%	6,675 $3.13 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $5,280 - $6,201	-17 Reduced 0.25%	6,845 $2.35 Million

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $97,429 - $113,525	-303 Reduced 4.23%	6,862 $2.51 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $13,341 - $15,204	45 Added 0.63%	7,165 $2.32 Million
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $68,288 - $80,181	245 Added 3.56%	7,120 $2.31 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $62,958 - $78,131	-280 Reduced 3.91%	6,875 $1.9 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $24,376 - $29,998	110 Added 1.56%	7,155 $1.65 Million
Q2 2021 Jul 15, 2021	BUY	$180.55 - $233.54 $53,262 - $68,894	295 Added 4.37%	7,045 $1.62 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $9,037 - $11,699	55 Added 0.82%	6,750 $1.26 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $6,523 - $8,631	50 Added 0.75%	6,695 $1.13 Million
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $48,983 - $56,658	-335 Reduced 4.8%	6,645 $984,000
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $36,969 - $44,492	271 Added 4.04%	6,980 $1.15 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $142,860 - $176,820	-1,200 Reduced 15.17%	6,709 $930,000
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $24,561 - $26,716	230 Added 3.0%	7,909 $884,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $41,546 - $48,495	-375 Reduced 4.66%	7,679 $851,000
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $91,274 - $107,436	820 Added 11.34%	8,054 $1.05 Million
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $24,568 - $27,524	232 Added 3.31%	7,234 $837,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $14,155 - $16,246	187 Added 2.74%	7,002 $597,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $14,841 - $17,520	-200 Reduced 2.85%	6,815 $527,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $574,809 - $616,548	7,015	7,015 $592,000

Others Institutions Holding LLY

# of Institutions

3,729

Shares Held

738M

Call Options Held

9.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $901B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.

Account

Aft, Forsyth & Company, Inc. Eli Lilly & CO Transaction History